United States v. Abbott Laboratories

Good Law
United States District Court, Southern District of CaliforniaApril 24, 20253:20-cv-00286California3,640 words

Opinion

Trial Court Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF CALIFORNIA 10 UNITED STATES OF AMERICA, et al. ex rel. Case No.: 20cv286-W (MSB) Everest Principals, LLC,

ORDER GRANTING DEFENDANTS’

Plaintiffs, MOTION TO COMPEL DISCOVERY v. 14 [ECF NO. 154] ABBOTT LABORATORIES, et al., 15 Defendants. 16 17 This is a qui tam case, wherein Plaintiff-Relator, Everest Principals, LLC (“Relator”) maintains causes of action against Defendants Abbott Laboratories, Abbott Laboratories Inc., Abbott Cardiovascular Systems Inc., and Abbott Vascular Inc. (collectively referred to as “Defendants” or “Abbott”) on behalf of the United States of America (“United States”) and several states for violations of the federal False Claims Act (“FCA”) and analogous state laws. (See ECF No. 85 at 6.) Now pending before this Court is the parties’ briefing regarding Relator’s response to Defendants’ Interrogatory No. 3. (See ECF Nos. 154 & 155.) In short, the parties disagree about whether Relator should be required to provide a complete list of allegedly…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.